Cordran Lotion Side Effects

Please note - some side effects for Cordran Lotion may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.

Cordran Lotion Side Effects - for the Professional

Cordran Lotion

The following local adverse reactions are reported infrequently with topical corticosteroids but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence:

    Burning
    Itching
    Irritation
    Dryness
    Folliculitis
    Hypertrichosis
    Acneform eruptions
    Hypopigmentation
    Perioral dermatitis
    Allergic contact dermatitis

    The following may occur more frequently with occlusive dressings:
    Maceration of the skin
    Secondary infection
    Skin atrophy
    Striae
    Miliaria

Postmarketing Adverse Reactions

 The following adverse reactions have been identified during post approval use of flurandrenolide lotion. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. 

Skin: skin striae, hypersensitivity, skin atrophy, contact dermatitis, and skin discoloration.

Side Effects by Body System - for Healthcare Professionals

Local

Local side effects have included burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, maceration of the skin, secondary infection, and miliaria. These effects are especially frequent and/or severe if the topical corticosteroid is applied to denuded skin or with occlusive dressings. Long-term use of topical corticosteroids may result in skin atrophy and thinning, and the development of striae, telangiectasia, subcutaneous hemorrhage, and easy bruising and bleeding. Allergic contact dermatitis is occasionally reported.

Endocrine

Endocrine side effects have included rare reports of hypothalamic-pituitary-adrenal (HPA) axis suppression. These reports were generally cases when higher potency topical corticosteroids were used over extensive areas and when occlusive dressings were used. HPA axis suppression has not been reported with flurandrenolide.

Dermatologic

Dermatologic side effects have included post marketing reports of skin striae, skin hypersensitivity, skin atrophy, contact dermatitis, and skin discoloration.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.